Trials / Completed
CompletedNCT02813239
Dual Triggering in Patients With a High Immature Oocyte Rate
Dual Triggering With Gonadotropin-releasing Hormone Agonist and Standard Dose Human Chorionic Gonadotropin in Patients With a High Immature Oocyte Rate
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 81 (actual)
- Sponsor
- IVI Madrid · Academic / Other
- Sex
- Female
- Age
- 18 Years – 43 Years
- Healthy volunteers
- Accepted
Summary
In in vitro fertilization (IVF) cycles, even after adequate triggering, some patients present a high rate of immature oocytes retrieved after controlled ovarian stimulation. In vitro oocyte maturation is still an experimental technique, with poorer results than conventional IVF. For that reason improve in in vivo maturation could have a better impact on reproductive outcome.
Detailed description
Investigators performed an observational study analyzing the difference in the percentage of mature oocytes retrieved in patients with more than 50% immature oocytes in a previous IVF cycle triggered with human chorionic gonadotropin (rhCG) compared to the rate of mature oocytes retrieved in subsequent cycles, triggered with both gonadotropin-releasing hormone agonist (GnRHa) and (hCG). The main outcome measure was the number and percentage of mature oocytes retrieved.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | hCG | Oocyte maturation with hCG |
| OTHER | hCG + GnRH agonist | Oocyte maturation with hCG + GnRH agonist |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2014-11-01
- Completion
- 2015-11-01
- First posted
- 2016-06-24
- Last updated
- 2016-06-24
Source: ClinicalTrials.gov record NCT02813239. Inclusion in this directory is not an endorsement.